Summit Securities Group’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-4,500
Closed -$22.8K – 1034
2025
Q3
$22.8K Buy
+4,500
New +$19.9K ﹤0.01% 743

Other funds holding SRTA

Summit Securities Group's SRTA Position: Q2 2026 in Review

Summit Securities Group opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 1,218 shares worth $6.42K. The stake represents ﹤0.01% of the portfolio and ranks #924 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in SRTA as recently as Q2 2025.

Summit Securities Group first reported a position in SRTA in Q2 2025 and has held it in 2 quarters since. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Summit Securities Group held 1,218 shares of Strata Critical Medical Inc worth $6.42K as of Q2 2026.
  • Strata Critical Medical Inc was a new Summit Securities Group position in Q2 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #924 holding.
  • Summit Securities Group first reported a position in Strata Critical Medical Inc in Q2 2025 and has held it in 2 quarters since.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.